{
    "2018-11-08": [
        [
            {
                "time": "",
                "original_text": "东吴证券：智飞生物增持评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "增持",
                        "评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【东吴晨报1108】【个股】智飞生物：签署HPV疫苗采购协议",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "采购协议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药|杜佐远团队太平洋证券】智飞生物(300122)：HPV基础采购额大幅上调，业绩贡献超预期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV",
                        "采购额",
                        "上调",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "HPV疫苗已在15个省级单位中标 智飞生物新增134亿元基础采购额",
                "features": {
                    "keywords": [
                        "HPV疫苗",
                        "中标",
                        "智飞生物",
                        "采购额"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物:签署HPV疫苗采购协议,为公司业绩增长提供保障",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "采购协议",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}